Turning on an immune pathway in tumors could lead to their destruction
November 3, 2025
MIT researchers show they can use messenger RNA to activate the pathway and trigger the immune system to attack tumors.
MIT researchers show they can use messenger RNA to activate the pathway and trigger the immune system to attack tumors.
Antibody unmasks pancreatic tumors’ ‘sugar-coated’ disguise to keep them from evading immune system
InterVene’s Recana is claimed to be the first fully integrated catheter system to address venous in-stent restenosis (ISR).
Pulsenmore announced today that it received FDA de novo clearance for its home-use prenatal ultrasound platform.
Wandercraft announced today that the FDA expanded the indications for its flagship Atalante X rehabilitation device.